Biopsy | Diagnosis | New Studies | Research
WHO to Recognize Fourth Mesothelioma Subtype
The World Health Organization will soon recognize mesothelioma in situ as a fourth mesothelioma subtype. The 2015 WHO classification of…
-
-
Canada | Chemotherapy | International | New Studies | Research | Treatments
Chemotherapy Resistance in Mesothelioma Patients: New Insights
Canadian cancer researchers have discovered what may be a key cause of chemotherapy resistance in mesothelioma and other types of… -
Diagnosis | Europe | International | New Studies | Research
Mesothelioma and COVID-19 Have Similar Psychological Challenges
Researchers in Italy say malignant mesothelioma and COVID-19 present patients with similar psychological challenges. In both cases, group therapy may… -
Europe | International | New Studies | Prognosis | Research
Predicting Mesothelioma Survival with Routine Clinical Tests
UK researchers say predicting mesothelioma survival does not have to be complicated. Their new study shows routine doctor’s office tests… -
Asia | International | New Drugs | New Studies | Research | Treatments
Spread of Peritoneal Mesothelioma Slows with Apatinib
An investigational drug called apatinib may help stop the growth and spread of peritoneal mesothelioma. Chinese researchers recently tested the… -
Biomarkers | Diagnosis | New Studies | New Techniques | Prognosis | Research | Treatments
Breakthroughs in Mesothelioma in 2020
In spite of a global pandemic, there were some major breakthroughs in mesothelioma in 2020 that made the year a… -
BLM Gene Mutation Increases Mesothelioma Risk, Study Finds
New research suggests an inherited mutation on the BLM gene increases susceptibility to deadly malignant mesothelioma. The research comes from… -
Cholesterol Drugs Extend Mesothelioma Survival in New Study
Cholesterol drugs called statins have been shown to improve survival among mesothelioma patients taking PD-1 inhibitors. The news comes from… -
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments
Induction Chemotherapy with Avastin Improves Mesothelioma Response in New Study
Mesothelioma patients who had induction chemotherapy with Avastin (bevacizumab) prior to surgery responded better than those who had only chemotherapy… -
Europe | Genetics | International | Research
Gene Editing Technology May Hold the Key to Curing Mesothelioma
New research on gene editing technology for cancer suggests that it could be the key to one day curing intractable…
